Medco Delivers Fourth-Quarter GAAP Diluted EPS Growth of 42 Percent; 2008 Full-Year GAAP Diluted EPS Growth of ...( Record Full-Year 2008 Mail-Order Volu...),Health

Record Full-Year 2008 Mail-Order Volume of Nearly 106 Million Prescriptions

Strong 2009 EPS Guidance Reaffirmed

Fourth-Quarter 2008 Highlights:

- GAAP diluted EPS increased 42.1 percent to $0.54 from $0.38 in 2007

- Diluted EPS, excluding $0.05 in amortization of intangible assets from the 2003 spin-off, increased 37.2 percent to $0.59 from $0.43 in 2007

- Record mail-order prescription volume of 26.7 million increased 9.4 percent from 2007

- EBITDA per adjusted prescription increased 25.2 percent to $3.18 compared to $2.54 in 2007

Full-Year 2008 Highlights:

- GAAP diluted EPS increased 30.7 percent to a record $2.13 from $1.63 in 2007

- Diluted EPS, excluding $0.20 in amortization of intangible assets from the 2003 spin-off, increased 28.0 percent to $2.33 from $1.82 in 2007

- Specialty pharmacy revenues rose 32.0 percent to a record $8.0 billion

- Record mail-order prescription volume of 105.8 million, increased 11.6 percent from 2007

- Generic dispensing rate increased 4.4 percentage points over 2007 to a full-year record of 64.1 percent

- EBITDA per adjusted prescription increased 15.7 percent to a full-year record of $3.09 compared to $2.67 in 2007

- Cash flow from operations increased 19.6 percent to a new record, exceeding $1.6 billion

2009 Guidance Reaffirmed:

- Full-year 2009 GAAP diluted EPS expected in the range of $2.45 to $2.55, representing 15 to 20 percent growth over 2008

- Full-year 2009 diluted EPS, excluding amortization of intangible assets, expected in the range of $2.67 to $2.77, representing 15 to 19 percent growth over 2008

FRANKLIN LAKES, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) today reported record full-year 200
'/>"/>